Home > Insider Trading > Filing (0001209191-23-023588)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1829069	Bastiano Sanna	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Cell & Genetic Therapies	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-04-04	211	$314.22	47,591	No	4	S	Direct
Common Stock	Disposition	2023-04-04	94	$315.66	47,497	No	4	S	Direct
Common Stock	Disposition	2023-04-04	90	$316.76	47,407	No	4	S	Direct
Common Stock	Disposition	2023-04-04	96	$317.65	47,311	No	4	S	Direct
Common Stock	Disposition	2023-04-04	31	$318.68	47,280	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1, which was entered into on 08/10/2022.
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $314.22 (range $313.72 to $314.70).
Open market sales reported on this line occurred at a weighted average price of $315.66 (range $315.08 to $315.96).
Open market sales reported on this line occurred at a weighted average price of $316.76 (range $316.41 to $317.20).
Open market sales reported on this line occurred at a weighted average price of $317.65 (range $317.49 to $317.74).